These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27295355)

  • 1. Activity of compounds from Taxillus sutchuenensis as inhibitors of HCV NS3 serine protease.
    Yang L; Lin J; Zhou B; Liu Y; Zhu B
    Nat Prod Res; 2017 Feb; 31(4):487-491. PubMed ID: 27295355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portulaca oleracea L. as a Prospective Candidate Inhibitor of Hepatitis C Virus NS3 Serine Protease.
    Noreen S; Hussain I; Tariq MI; Ijaz B; Iqbal S; Qamar-ul-Zaman ; Ashfaq UA; Husnain T
    Viral Immunol; 2015 Jun; 28(5):282-9. PubMed ID: 25871297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease.
    Duan D; Li Z; Luo H; Zhang W; Chen L; Xu X
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6041-4. PubMed ID: 15546725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel high throughput screening assay for HCV NS3 serine protease inhibitors.
    Berdichevsky Y; Zemel R; Bachmatov L; Abramovich A; Koren R; Sathiyamoorthy P; Golan-Goldhirsh A; Tur-Kaspa R; Benhar I
    J Virol Methods; 2003 Feb; 107(2):245-55. PubMed ID: 12505640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
    Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
    J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
    Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
    Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a novel poliovirus with a requirement of hepatitis C virus protease NS3 activity.
    Hahm B; Back SH; Lee TG; Wimmer E; Jang SK
    Virology; 1996 Dec; 226(2):318-26. PubMed ID: 8955051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
    Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
    Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel peptidyl α-aminoalkylphosphonates as inhibitors of hepatitis C virus NS3/4A protease.
    Skoreński M; Pachota M; Pyrć K; Sieńczyk M; Oleksyszyn J
    Antiviral Res; 2017 Aug; 144():286-298. PubMed ID: 28673801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
    Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors.
    Lee JC; Yu MC; Lien TW; Chang CF; Hsu JT
    Assay Drug Dev Technol; 2005 Aug; 3(4):385-92. PubMed ID: 16180993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and structure of SCH 351633: a novel hepatitis C virus (HCV) NS3 protease inhibitor from the fungus Penicillium griseofulvum.
    Chu M; Mierzwa R; He L; King A; Patel M; Pichardo J; Hart A; Butkiewicz N; Puar MS
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1949-52. PubMed ID: 10450960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for induced fit docking (GENIUS) and its application to virtual screening of novel HCV NS3-4A protease inhibitors.
    Takaya D; Yamashita A; Kamijo K; Gomi J; Ito M; Maekawa S; Enomoto N; Sakamoto N; Watanabe Y; Arai R; Umeyama H; Honma T; Matsumoto T; Yokoyama S
    Bioorg Med Chem; 2011 Nov; 19(22):6892-905. PubMed ID: 21992802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies of a bisbenzimidazole-based, Zn(2+)-dependent inhibitor of HCV NS3 serine protease.
    Yeung KS; Meanwell NA; Qiu Z; Hernandez D; Zhang S; McPhee F; Weinheimer S; Clark JM; Janc JW
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2355-9. PubMed ID: 11527730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent aza-peptide derived inhibitors of HCV NS3 protease.
    Venkatraman S; Wu W; Shih NY; George Njoroge F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4760-3. PubMed ID: 19596195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling based approach, synthesis and in vitro assay to new indole inhibitors of hepatitis C NS3/4A serine protease.
    Ismail NS; Hattori M
    Bioorg Med Chem; 2011 Jan; 19(1):374-83. PubMed ID: 21138791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
    Tsantrizos YS
    Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant, anti-inflammatory, and antiproliferative activities of Taxillus sutchuenensis.
    Liu CY; Lin YC; Deng JS; Liao JC; Peng WH; Huang GJ
    Am J Chin Med; 2012; 40(2):335-48. PubMed ID: 22419427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of oxygen-containing macrocyclic peptidomimetics as inhibitors of HCV NS3 protease.
    Velázquez F; Venkatraman S; Blackman M; Pinto P; Bogen S; Sannigrahi M; Chen K; Pichardo J; Hart A; Tong X; Girijavallabhan V; Njoroge FG
    J Med Chem; 2009 Feb; 52(3):700-8. PubMed ID: 19154150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.